sb 203580 has been researched along with glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine) | Trials (glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine) | Recent Studies (post-2010) (glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 12 | 0 | 1 |
| Protein | Taxonomy | sb 203580 (IC50) | glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.78 | |
| Integrin alpha-V | Homo sapiens (human) | 0.4733 | |
| Integrin alpha-IIb | Homo sapiens (human) | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frewin, MB; Gudewicz, PW; Xythalis, D | 1 |
1 other study(ies) available for sb 203580 and glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine
| Article | Year |
|---|---|
Inhibition of IL-8-mediated MAPK activation in human neutrophils by beta1 integrin ligands.
Topics: Antibodies, Monoclonal; Chemotaxis, Leukocyte; Enzyme Activation; Enzyme Inhibitors; Fibronectins; Flavonoids; Humans; Imidazoles; Integrin alpha5beta1; Integrin alpha6beta1; Integrin beta1; Interleukin-8; Laminin; Ligands; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neutrophils; Oligopeptides; Peptide Fragments; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Recombinant Proteins | 2002 |